Brief: The U.S. Food And Drug Administration Completes Review Of Cibus’ Altered Lignin Alfalfa
24/06/2025 12:09
June 24 (Reuters) - Cibus Inc CBUS.O: THE U.S. FOOD AND DRUG ADMINISTRATION COMPLETES REVIEW OF CIBUS’ ALTERED LIGNIN ALFALFA DEVELOPED IN PARTNERSHIP WITH S&W SEED COMPANY FOR USE IN LIVESTOCK FEED CIBUS INC - FDA HAS NO FURTHER QUESTIONS ON ALTERED LIGNIN ALFALFA Source text: ID:nGNX8ZCNwn Further company coverage: CBUS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cibus
See all newsCibus Inc reports results for the quarter ended June 30 - Earnings Summary
Cibus Q2 revenue rises, loss narrows on cost cuts
Cibus Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Cibus Inc - To Offer Securities With Aggregate Initial Offering Price Up To $200 Million - SEC Filing
Cibus Q1 revenue rises and beats analyst estimates